DRUG TS-104: A prospective randomized clinical trial on 90Yttrium trans-arterial radio-Embolization (TheraSphere®) vs. Sorafenib for the treatment of advanced Hepatocellular Carcinoma (HCC) with Portal Vein Thrombosis (PVT)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/5/136/5/16

Funding

  • Theorem Clinical Research (DRUG TS-104)
  • Biocompatibles UK Ltd. (DRUG TS-104)